The Role of Small Intestinal Bacterial Overgrowth in Rosacea: A 3-year Follow-Up

J Am Acad Dermatol. 2016 Sep;75(3):e113-e115. doi: 10.1016/j.jaad.2016.01.059.

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Blind Loop Syndrome / complications*
  • Blind Loop Syndrome / drug therapy
  • Follow-Up Studies
  • Humans
  • Intestine, Small / microbiology*
  • Middle Aged
  • Remission Induction
  • Rifamycins / therapeutic use
  • Rifaximin
  • Rosacea / complications*
  • Rosacea / microbiology*
  • Rosacea / therapy

Substances

  • Anti-Bacterial Agents
  • Rifamycins
  • Rifaximin